State Of Wyoming Amphastar Pharmaceuticals, Inc. Transaction History

State Of Wyoming

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$42.85 - $63.45 $28,666 - $42,448	669 Added 81.78%	1,487 $65,000
Q4 2023 Feb 14, 2024	SELL	$44.49 - $62.93 $23,312 - $32,975	-524 Reduced 39.05%	818 $50,000
Q3 2023 Nov 14, 2023	SELL	$45.51 - $65.0 $154,779 - $221,065	-3,401 Reduced 71.71%	1,342 $61,000
Q2 2023 Aug 14, 2023	BUY	$35.77 - $58.38 $134,065 - $218,808	3,748 Added 376.68%	4,743 $272,000
Q1 2023 May 12, 2023	SELL	$27.99 - $37.92 $79,491 - $107,692	-2,840 Reduced 74.05%	995 $37,000
Q4 2022 Feb 14, 2023	BUY	$27.93 - $31.27 $46,587 - $52,158	1,668 Added 76.97%	3,835 $107,000
Q3 2022 Nov 14, 2022	BUY	$27.56 - $37.75 $3,141 - $4,303	114 Added 5.55%	2,167 $61,000
Q2 2022 Aug 15, 2022	SELL	$29.79 - $42.29 $33,335 - $47,322	-1,119 Reduced 35.28%	2,053 $71,000
Q1 2022 May 13, 2022	BUY	$22.96 - $36.45 $13,500 - $21,432	588 Added 22.76%	3,172 $114,000
Q4 2021 Feb 11, 2022	BUY	$18.14 - $23.29 $46,873 - $60,181	2,584 New	2,584 $60,000

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.